oann

Centene boosts profit outlook due to robust premium growth.

(Reuters) – Centene Corp ⁣on Friday raised its‍ full-year earnings forecast⁤ and beat Wall‍ Street estimates for second-quarter profit on strong growth in premium collections.

The health insurer raised its 2023 full-year adjusted profit forecast by ‌5 cents to at least $6.45 per share.

Advertisement

It increased​ its‍ 2023 ‍premium and services revenue forecast range by $1.8 billion.

Excluding items, Centene earned $2.10 per share in the⁣ second ⁣quarter, above​ Refinitiv IBES⁤ estimates of $2.03.

(Reporting by ⁤Mariam Sunny and Leroy Leo in Bengaluru; Editing by ‌Shinjini Ganguli)

Jim Jordan provides evidence of #COVID19 censorship while it’s a⁤ weekend ⁤at Feinstein’s in ‍the⁣ Senate

Republicans are accusing Alejandro Mayorkas of dereliction of duty as he maintains the border is secure

A California school⁤ board ⁣president says she is facing several threats over a⁢ recent policy decision aimed at empowering ⁤parents.

During ‍a hearing on the ‍‘Dangers and due ⁢process violations of ​gender affirming care ​for children” ethical ‍arguments from both⁣ sides were brought up.

By Munsif Vengattil and Sumit ⁤Khanna GANDHINAGAR, India (Reuters) – India⁢ wants​ to ⁣emerge as a trusted partner for the ⁣semiconductor industry…

By ⁤Victor ⁢Goury-Laffont ⁤(Reuters) -France’s⁤ Atos on Friday ⁣reported a wider ‌half-year operating loss due to restructuring costs related ​to ​its planned…

TOKYO (Reuters) -Japan’s Panasonic Holdings and automaker Subaru are expected ‌to announce plans‍ for an electric​ vehicle battery partnership soon, the​ Nikkei…

By Sam Nussey, Miho Uranaka and Makiko Yamazaki⁣ TOKYO (Reuters) – JSR Corp,⁢ which plans‌ a $6.4 billion sale to a government-backed…


Read More From Original Article Here: Centene raises profit forecast on strong premium growth

" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."

Related Articles

Sponsored Content
Back to top button
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker